Is Tarsus Pharmaceuticals TARS stock failing to hold levels Tarsus Pharmaceuticals posts wider than expected EPS loss Centene Corporation CNC ShortTerm Momentum Masks Structural Profitability Headwinds NBHC National posts 87 percent Q1 2026 EPS beat shares slip 079 percent amid cautious investor sentiment